Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • M.D., University of Pittsburgh 1992
• 

  Previous Appointments & Affiliations

  • Associate Professor of Medicine, Medicine, General Internal Medicine, Medicine 2009 - 2012
  • Associate Professor of Medicine, Duke University 2008 - 2009
  • Associate Professor of Medicine, Medicine, General Internal Medicine, Medicine 2006 - 2008
  • Associate Clinical Professor of Medicine, Medicine, General Internal Medicine, Medicine 2004 - 2006
  • Assistant Clinical Professor of Medicine, Medicine, General Internal Medicine, Medicine 1999 - 2004
  • Associate in the Department of Medicine, Medicine, General Internal Medicine, Medicine 1997 - 1999
  • Instructor, Temporary in the Department of Medicine, Medicine, General Internal Medicine, Medicine 1997
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Cho, Alex H., Ley A. Killeya-Jones, Julianne M. O’Daniel, Kensaku Kawamoto, Patrick Gallagher, Susanne Haga, Joseph E. Lucas, Gloria M. Trujillo, Scott V. Joy, and Geoffrey S. Ginsburg. “Effect of genetic testing for risk of type 2 diabetes mellitus on health behaviors and outcomes: study rationale, development and design.” Bmc Health Serv Res 12 (January 18, 2012): 16. https://doi.org/10.1186/1472-6963-12-16.
       Full Text  Open Access Copy  Link to Item
    • Joy, S. V., J. S. Freeman, and J. R. LaSalle. “Tailoring treatment for type 2 diabetes: Uncovering the HOW and NOW of GLP-1 receptor agonist therapy.” Osteopathic Family Physician 3, no. 5 (2011): 217–36. https://doi.org/10.1016/j.osfp.2011.07.002.
       Full Text
    • Kawamoto, Kensaku, Lori A. Orlando, Deepak Voora, David F. Lobach, Scott Joy, Alex Cho, and Geoffrey S. Ginsburg. “Evaluation of the PharmGKB knowledge base as a resource for efficiently assessing the clinical validity and utility of pharmacogenetic assays.” Amia Annu Symp Proc 2009 (November 14, 2009): 307–11.
       Link to Item
    • Joy, Scott V. “Clinical pearls and strategies to optimize patient outcomes.” Diabetes Educ 34 Suppl 3 (2008): 54S-59S. https://doi.org/10.1177/0145721708319233.
       Full Text  Link to Item
    • Joy, S. V. “Clinical pearls and strategies to optimize patient outcomes.” Journal of the American Academy of Nurse Practitioners 19, no. SUPPL. 1 (2007): 15–20. https://doi.org/10.1111/j.1745-7599.2007.00286.x.
       Full Text
    • Taulien, Christina A., and Scott V. Joy. “Ruboxistaurin.” Drugs Today (Barc) 42, no. 9 (September 2006): 577–85. https://doi.org/10.1358/dot.2006.42.9.996566.
       Full Text  Link to Item
    • Joy, Scott V., Ann C. Scates, Srilaxmi Bearelly, Moahad Dar, Christina A. Taulien, Jason A. Goebel, and Michael J. Cooney. “Ruboxistaurin, a protein kinase C beta inhibitor, as an emerging treatment for diabetes microvascular complications.” Ann Pharmacother 39, no. 10 (October 2005): 1693–99. https://doi.org/10.1345/aph.1E572.
       Full Text  Link to Item
    • Joy, Scott V., Philip T. Rodgers, and Ann C. Scates. “Incretin mimetics as emerging treatments for type 2 diabetes.” Ann Pharmacother 39, no. 1 (January 2005): 110–18. https://doi.org/10.1345/aph.1E245.
       Full Text  Link to Item
    • Joy, S. V., J. A. Gouveia-Pisano, and S. M. Diaz. “An experience in creating a men's health electronic registry in a primary care setting.” Journal of Clinical Outcomes Management 11, no. 4 (April 1, 2004): 223–28.
    • Ressler, Ilana B., Jayne Cash, Diana McNeill, Scott Joy, and Philip M. Rosoff. “Continued parental attendance at a clinic for adult survivors of childhood cancer.” J Pediatr Hematol Oncol 25, no. 11 (November 2003): 868–73. https://doi.org/10.1097/00043426-200311000-00009.
       Full Text  Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.